Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus.
about
Therapeutic Use of Metformin in Prediabetes and Diabetes PreventionMetformin and the gastrointestinal tractGut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studiesRole of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseUnacylated ghrelin modulates circulating angiogenic cell number in insulin-resistant states.Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.Combination of linagliptin and metformin for the treatment of patients with type 2 diabetes.Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance.Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.Linagliptin plus metformin: a pharmacokinetic and pharmacodynamic evaluation.Efficacy and safety of Jentadueto® (linagliptin plus metformin).Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence.Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes.Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes.Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.
P2860
Q26822066-EF9A13B6-F5CF-4000-97B9-7067A8E5359CQ28079250-C31E7B8B-C785-4CB9-87AC-83E862008787Q28541879-5437863C-3754-4062-869B-726394C6A925Q33607697-D0C39ABA-FEEC-4183-AFAF-4692CD6DE4C3Q33749878-FF98CA60-0FB8-4185-A049-358C6331A356Q33838229-58B1F1AA-CED4-4EA9-BC43-584CFF405125Q34824247-A94E0EEC-BD2D-4F96-9B7D-7260A33D1C78Q35085434-826200F7-9098-4083-A612-07ED6FBDFDA3Q35116119-5777FB5D-AE7A-4673-ACA2-E1A59292A05FQ37366826-962132FB-49DA-4BF7-A69C-D9A746A37E65Q38055195-F5E80A4B-6C9D-4748-8FE2-1CF1CCEC3A9EQ38078436-CA0A44B3-F06D-4075-8C1B-49D1E135D89BQ38082848-15AFBC72-D56F-46C9-A39A-1E22CD1E3D1AQ38106411-BBB41F32-EBCD-4498-B79A-A406DC8947D9Q38855893-48827D7F-D306-4406-B6AC-1466EC524390Q40468370-2298BF8A-7F60-4829-B59E-83844A18801DQ44685753-93CA99FF-E49B-466B-AD85-6A3A55BA0F83Q48189728-D0C87DFD-E041-4F30-870E-BA4B737645B6Q55401717-D4140109-5079-4107-AFB7-DBD12A2B5993
P2860
Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Effects of chronic treatment w ...... with Type 2 diabetes mellitus.
@en
Effects of chronic treatment w ...... with Type 2 diabetes mellitus.
@nl
type
label
Effects of chronic treatment w ...... with Type 2 diabetes mellitus.
@en
Effects of chronic treatment w ...... with Type 2 diabetes mellitus.
@nl
prefLabel
Effects of chronic treatment w ...... with Type 2 diabetes mellitus.
@en
Effects of chronic treatment w ...... with Type 2 diabetes mellitus.
@nl
P2093
P2860
P921
P1433
P1476
Effects of chronic treatment w ...... with Type 2 diabetes mellitus
@en
P2093
P2860
P304
P356
10.1111/J.1464-5491.2012.03675.X
P577
2012-08-01T00:00:00Z